Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-121435

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John McGrath
Officer — Chief Financial Officer
Period of report
May 16, 2016
Accepted (ET)
May 18, 2016 · 7:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 16, 2016M2,805$0.00A86,519D
Common StockF1May 16, 2016M7,698$0.00A94,217D
Commono StockF4May 16, 2016S5,395$15.77D88,822D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF8,F5,F6,F7—May 16, 2016M2,805D——Common Stock2,8059,348I
Restricted Stock UnitsF8,F5,F9,F10—May 16, 2016M7,698D——Common Stock7,69851,316I

Explanation of responses